- A partnership between Microsoft, Tevogen Bio Holdings Inc., Databricks, and Genmab was announced on August 23, 2025, accelerating therapeutic discovery and development.
- Microsoft, Tevogen Bio Holdings Inc., and Databricks are collaborating to build the PredicTcell model for oncology applications.
- A partnership between Microsoft, Tevogen Bio Holdings Inc., Databricks, and Genmab was announced on August 23, 2025, accelerating therapeutic discovery and development.
- Microsoft, Tevogen Bio Holdings Inc., and Databricks are collaborating to build the PredicTcell model for oncology applications.
A partnership between Microsoft, Tevogen Bio Holdings Inc., Databricks, and Genmab was announced on August 23, 2025, accelerating therapeutic discovery and development.
6 reports, 1 independent
Updated Aug 23
Gone quiet
- Reports
- 6
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A partnership between Microsoft, Tevogen Bio Holdings Inc., Databricks, and Genmab was announced on August 23, 2025, accelerating therapeutic discovery and development.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Microsoft, Tevogen Bio Holdings Inc., and Databricks are collaborating to build the PredicTcell model for oncology applications.Sub-event
Partnership accelerates therapeutic discovery and development.1 source
Strategic partnerships accelerate Tevogen's progress.1 source
Keep exploring
The entities involved
-
Microsoft
American multinational technology corporation
- Major tech companies, including Meta, Microsoft, Amazon, OpenAI, and Oracle, are involved in an AI arms race that is influenced by Trump-era tariffs, with potential acquisitions mentioned regarding Siri.
- Broadcom partners with hyperscalers like Amazon and Microsoft, offering custom ASICs to diversify from reliance on Nvidia's standard offerings.
-
Databricks
American technology company
-
Genmab
Danish healthcare company
Coverage
Newest first; wire copies grouped- GlobeNewswireTevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma WARREN, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or the “
- GlobeNewswireRepeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology Tevogen.AI to explore external market opportunitie
- GlobeNewswireREPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Compa
- GlobeNewswireTevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nas
- GlobeNewswireTevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.”
- GlobeNewswireTevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market f